Oracle’s 3rd Annual Drug Development and Safety Forum 2009- India


Oracle’s 3rd Annual Drug Development and Safety Forum 2009

October 21 – 22, 2009

Oracle invites you to the 2009 Drug Development and Safety Forum

At this forum we will be discussing important topics and issues facing the Indian Pharmaceutical Biotechnology, and CRO industry. This event will be highlighted by presentations from key industry thought leaders who will share their perspective on industry best practices as well as their unique experiences.

The content will cover important topics in clinical development, and safety. You will hear how Oracle solutions have enabled organizations in the industry shorten their time to market, gain operational efficiencies, reduce clinical study costs and accelerate insight into action

As a follow up to the success of last two year’s Clinical Development and Safety Forum this year’s event will prove to be a must attend event.

October 21 – 22, 2009

The Leela Kempinski
Sahar, Mumbai, India

To Register Now , contact Sushma at +91 80 4029 1295 (include your name, company, e-mail address, contact mobile number, arrival/departure – dates/time).

•    Keynote Presentations
•    Networking lunch
•    Networking Dinner on the first day
•    Perspectives from industry strategists and thought leaders
•    Hear about business best practices and lessons learned from leading companies
•    A unique networking opportunity with colleagues, industry and Oracle experts

Korean Contract Research Organization to Use Oracle Clinical and Oracle Remote Data Capture

Jul 22, 2009 08:00 ET

DreamCIS Selects Oracle® Health Sciences Applications to Accelerate and Simplify Clinical Trial Data Collection

Leading Korean Contract Research Organization to Use Oracle Clinical and Oracle Remote Data Capture Applications

News Facts

  • DreamCIS, a leading contract research organization (CRO) in Korea, has selected Oracle® Health Sciences applications to help increase efficiency in clinical trials data collection and improve data quality.
  • DreamCIS required a robust, reliable and scalable clinical trial management system to replace its legacy clinical software solution and help enable the company’s biometrics center to become an Asian clinical trial data management hub.
  • DreamCIS intends to use Oracle Clinical and Oracle Remote Data Capture (RDC) 4.5.3 to help meet global standards for clinical trials data management and achieve higher quality local clinical trial services.
  • Oracle Health Sciences provides the life sciences sector with the most integrated clinical data management and electronic data capture applications available today, while also providing best-in-class functionality.
  • Oracle RDC 4.5.3 uses the same data model as Oracle Clinical, ensuring tight integration of data between these applications.
  • Oracle RDC 4.5.3 is also completely Web-based, with a ‘zero client footprint’ for the HTML data entry window. This enables improved global access and performance for life sciences organizations to conduct global clinical studies more cost effectively whether using traditional pen and paper, electronic data capture, or hybrid methods.
  • Oracle Clinical and Oracle Remote Data Capture are widely adopted by global health science organizations including CROs, pharmaceutical and biotechnology companies. DreamCIS is the first CRO in Korea to adopt the applications.

Supporting Quotes

  • “Oracle Health Sciences applications are not only equipped with outstanding technology but also offer superior system reliability, compatibility and compliance,” said Hee-Joong Koh, Director, Biometrics Center, DreamCIS. “Oracle’s proven experience in the health sciences sector was important to us and we believe their solutions will enable us to raise our data management levels to global standards, and help us become the leader in the Asian clinical trial markets in the future.”
  • “As the number of clinical trials increases in the Korean market and throughout Asia, there is a growing need for best-in-class software applications for clinical development and drug safety,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “We are committed to helping emerging CROs like DreamCIS accelerate insights for better health and look forward to supporting their efforts to become an important hub for clinical data management in the region.”

Supporting Resources

Oracle at DIA announces new initiatives

Oracle is certainly on a role, the company has not only released several new web2.0 platform based applications, and already embraced the new technology for its sales ,marketing, customer support and customer outreach programes.

The last week so the launch of the Official facebook and twitter accounts for the Oracle Global Healthscience Business. Today Oracle has announced a slew of new intiatives for its partners, that take advantge of web2.0 to provide training and support.

Oracle twitter at @OracleHealthSci and  newly published Oracle Health Sciences fan page on Facebook. I have to admit despite that fact that I started blogging almost 6 years ago, I still do not have a facebook account. Now I have the best reason to create one.- with a smile , I am sure this time I have the support of my Oragnization to put it to good use.

 At DIA today among other announcements oracle has made is the decision to Focuses on Health Sciences Partner Enablement, Growth, and Accreditation.

At the heart of this new initiatives will be the Oracle Health Sciences Knowledge Zone  for partners and customers to connect with peers, participate in a variety of Web 2.0 networks, and engage in opportunities within Oracle’s healthcare and life sciences ecosystem.


Join the Oracle Health Sciences for Partners Group on Oracle Mix

%d bloggers like this: